메뉴 건너뛰기




Volumn 172, Issue 15, 2012, Pages 1186-1187

Prescription drug abuse and DEA-sanctioned drug take-back events: Characteristics and outcomes in rural appalachia

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUTALBITAL; CENTRAL STIMULANT AGENT; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DICHLORALPHENAZONE; DRONABINOL; FENTANYL; HYDROCODONE; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; ISOMETHEPTENE MUCATE; METHADONE; MODAFINIL; OPIATE; OXYCODONE; OXYCODONE PLUS OXYCODONE TEREPHTHALATE PLUS PARACETAMOL; PARACETAMOL; PETHIDINE; PHENTERMINE; PREGABALIN; SPASMOLYTIC AGENT; TESTOSTERONE; TRAMADOL;

EID: 84865683795     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2012.2374     Document Type: Article
Times cited : (38)

References (6)
  • 3
    • 84872496124 scopus 로고    scopus 로고
    • Drug Enforcement Administration, Office of Diversion Control Web site Accessed November 3, 2011
    • National take-back initiative. US Department of Justice, Drug Enforcement Administration, Office of Diversion Control Web site. http://www.deadiversion. usdoj.gov/drug-disposal/takeback/index.html. Accessed November 3, 2011.
    • National Take-back Initiative
  • 5
    • 84872431008 scopus 로고    scopus 로고
    • Web site Accessed March 5, 2012
    • Prescription drug abuse. Office of National Drug Control Policy Web site. http://www.whitehouse.gov/ondcp/prescription-drug-abuse. Accessed March 5, 2012.
    • Prescription Drug Abuse


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.